Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
about
Influenza: the once and future pandemicA highly conserved neutralizing epitope on group 2 influenza A virusesStructural characterization of viral epitopes recognized by broadly cross-reactive antibodiesUniversal immunity to influenza must outwit immune evasionH5N1 vaccines in humansBroadly neutralizing antibodies against influenza virus and prospects for universal therapiesSignificant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infectionsMonoclonal antibody-based therapies for microbial diseasesA neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutininsCross-neutralization of influenza A viruses mediated by a single antibody loopHeterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidityInfluenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 VirusesA recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutininConserved Neutralizing Epitope at Globular Head of Hemagglutinin in H3N2 Influenza VirusesTwo Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding AntibodyAn influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coliLarge-scale analysis of B-cell epitopes on influenza virus hemagglutinin - implications for cross-reactivity of neutralizing antibodies.Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases.One step closer to universal influenza epitopes.Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.Continuing challenges in influenza.Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutininAdenoviral vectors as novel vaccines for influenza.An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infectionHuman monoclonal antibodies targeting the haemagglutinin glycoprotein can neutralize H7N9 influenza virus.Serum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses.Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses.The Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin.Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccineSpecific recognition of influenza A/H1N1/2009 antibodies in human serum: a simple virus-free ELISA method.Intranasal delivery of an IgA monoclonal antibody effective against sublethal H5N1 influenza virus infection in miceA cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection.Human monoclonal antibodies broadly neutralizing against influenza B virus.Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.Hallmarks of CD4 T cell immunity against influenzaIdentification of a highly conserved H1 subtype-specific epitope with diagnostic potential in the hemagglutinin protein of influenza A virus.Targets for the induction of protective immunity against influenza a viruses.A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.New technologies for influenza vaccines.Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses
P2860
Q24630177-B2264128-08B5-4E5E-8A82-CDDD5ACFF20FQ24630467-B9CA2EEA-3796-4339-A729-C12D27561F4FQ26823492-5D57480A-6FDF-471A-86D8-07D9BB5B4FC7Q26991896-E9980CA2-7877-4BAF-A75C-A18AD40FDFF9Q27000896-C0AA06DA-DE61-4D05-ACD6-D2F0B59A76DDQ27010503-1C59E975-861C-4393-8ADD-B95694FE665DQ27329554-36B5AB46-0597-4624-BD43-882FFD3B400CQ27490830-ACB5C435-4640-4F57-97DC-729E2C2344DFQ27671165-D9541BB6-D354-4885-BC89-C01A0F23F5AFQ27673206-C2654CF9-CD9A-40D6-9C32-073953D2BF33Q27673861-62E7CF06-7065-44B7-B0B4-5F3C8EB07769Q27675477-214D7151-2AC9-4C67-97A8-F050DD73B490Q27676298-94B6BA67-8B88-4D44-9381-4D7509CFEAC5Q27683198-43068F4E-730F-4701-AEFD-05E90256B959Q28552195-0C897BCD-89A6-42E4-82DF-C818753FED22Q28750246-5DC61469-73D2-4D0F-A41E-2D0F17F97C27Q30217235-E446C93F-8543-4D16-BAB0-7EC538D8C9A8Q30222441-27E14BAD-E989-4B62-BE53-9A585681B91DQ30227646-8AAA1B09-D188-4B50-8C26-03AD808C59E0Q30358388-B91691F7-F960-4E49-B6B6-58ED7354D075Q30363190-D59BE7DE-2EB2-4BE4-BA0B-0D0CDF82FA02Q30363595-BA261014-2D1C-4F1B-83C9-F0BBC66AAD25Q30370445-2C8D6B8F-4B75-417B-911D-A9AEA15A7E52Q30371674-1CE941F1-318A-497D-B02D-6CF94FC57527Q30373175-0918C09A-2F81-4323-8721-2628C2C67F9BQ30377531-0B4254B8-D8D6-4868-98E9-C516C88FD8C4Q30383987-995BAC11-89F3-43A1-BA2D-90EA28870D5EQ30387177-2C448E5D-3BF8-4148-B35B-29212FC7902AQ30388038-539A7F38-6197-4C2E-973C-06E5DAE4DABCQ30388531-AE2D5D64-CDDC-4ED4-99C2-05286F03D306Q30391974-D60A25B3-140C-492A-9C3A-F15A05A78BF0Q30393843-7989E29E-2F8D-471E-98F2-CFA89A4B68CFQ30394240-A822B950-F0FD-401A-85CB-C72E591591F2Q30397107-86FC18FF-4F25-44CA-A132-94BEB2D98D42Q30400290-C93F9BEC-1959-446F-AB0C-0C952DE25423Q30406634-B4056C04-EC02-4B00-AA87-6D71D8BB30CBQ30408100-36F67144-2210-4791-A27A-9403022C0D6FQ30411637-369BD89E-E48E-4F6A-9458-AC557F904999Q30411859-B1E66188-820D-447C-A69A-F5632A667FEAQ30414712-42D9AAAB-DCC2-452A-B36F-E9144D23DEDF
P2860
Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cross-protective potential of ...... utinin of influenza A viruses.
@ast
Cross-protective potential of ...... utinin of influenza A viruses.
@en
type
label
Cross-protective potential of ...... utinin of influenza A viruses.
@ast
Cross-protective potential of ...... utinin of influenza A viruses.
@en
prefLabel
Cross-protective potential of ...... utinin of influenza A viruses.
@ast
Cross-protective potential of ...... utinin of influenza A viruses.
@en
P2093
P2860
P1433
P1476
Cross-protective potential of ...... utinin of influenza A viruses.
@en
P2093
Ayato Takada
Daisuke Tomabechi
Hiroichi Ozaki
Hiroshi Kida
Manabu Igarashi
Noriko Kishida
Reiko Yoshida
P2860
P304
P356
10.1371/JOURNAL.PPAT.1000350
P50
P577
2009-03-20T00:00:00Z